Phrontline Biopharma

Developer of therapeutics for various diseases

placePudong, Shanghai, China calendar_todayFounded 2022 language phrontlinebio.com

Investor mix

10 investors on record; lead investors include Lapam Capital.

Investor typeCountShare
Venture capital550%
Other / undisclosed550%
Coming soon